These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

460 related items for PubMed ID: 22237953

  • 1. Immunosuppression induction with rabbit anti-thymocyte globulin with or without rituximab in 1000 liver transplant patients with long-term follow-up.
    Mangus RS, Fridell JA, Vianna RM, Kwo PY, Chen J, Tector AJ.
    Liver Transpl; 2012 Jul; 18(7):786-95. PubMed ID: 22237953
    [Abstract] [Full Text] [Related]

  • 2. Promising early results with immunosuppression using rabbit anti-thymocyte globulin and steroids with delayed introduction of tacrolimus in adult liver transplant recipients.
    Tector AJ, Fridell JA, Mangus RS, Shah A, Milgrom M, Kwo P, Chalasani N, Yoo H, Rouch D, Liangpunsakul S, Herring S, Lumeng L.
    Liver Transpl; 2004 Mar; 10(3):404-7. PubMed ID: 15004768
    [Abstract] [Full Text] [Related]

  • 3. Reduced dose rabbit anti-thymocyte globulin induction for prevention of acute rejection in high-risk kidney transplant recipients.
    Klem P, Cooper JE, Weiss AS, Gralla J, Owen P, Chan L, Wiseman AC.
    Transplantation; 2009 Oct 15; 88(7):891-6. PubMed ID: 19935460
    [Abstract] [Full Text] [Related]

  • 4. Steroid-free liver transplantation using rabbit antithymocyte globulin induction: results of a prospective randomized trial.
    Eason JD, Loss GE, Blazek J, Nair S, Mason AL.
    Liver Transpl; 2001 Aug 15; 7(8):693-7. PubMed ID: 11510013
    [Abstract] [Full Text] [Related]

  • 5. Renal transplantation in the setting of early steroid withdrawal: a comparison of rabbit antithymocyte globulin induction dosing in two eras.
    Rogers CC, Asipenko N, Horwedel T, Gautam S, Goldfarb-Rumyantzev AS, Pavlakis M, Johnson SR, Karp SJ, Evenson A, Khwaja K, Hanto DW, Mandelbrot DA.
    Am J Nephrol; 2013 Aug 15; 38(5):397-404. PubMed ID: 24192457
    [Abstract] [Full Text] [Related]

  • 6. Preserving renal function in liver transplant recipients with rabbit anti-thymocyte globulin and delayed initiation of calcineurin inhibitors.
    Bajjoka I, Hsaiky L, Brown K, Abouljoud M.
    Liver Transpl; 2008 Jan 15; 14(1):66-72. PubMed ID: 18161842
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of a Weight-based Rabbit Anti-thymocyte Globulin Induction Dosing Regimen for Kidney Transplant Recipients.
    Pennington CA, Tischer SM, Lee E, Lee S, Sindelar J, Park JM.
    Pharmacotherapy; 2015 Aug 15; 35(8):748-54. PubMed ID: 26234282
    [Abstract] [Full Text] [Related]

  • 8. A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation.
    Farney AC, Doares W, Rogers J, Singh R, Hartmann E, Hart L, Ashcraft E, Reeves-Daniels A, Gautreaux M, Iskandar SS, Moore P, Adams PL, Stratta RJ.
    Transplantation; 2009 Sep 27; 88(6):810-9. PubMed ID: 19920781
    [Abstract] [Full Text] [Related]

  • 9. Randomized trial of single-dose versus divided-dose rabbit anti-thymocyte globulin induction in renal transplantation: an interim report.
    Stevens RB, Mercer DF, Grant WJ, Freifeld AG, Lane JT, Groggel GC, Rigley TH, Nielsen KJ, Henning ME, Skorupa JY, Skorupa AJ, Christensen KA, Sandoz JP, Kellogg AM, Langnas AN, Wrenshall LE.
    Transplantation; 2008 May 27; 85(10):1391-9. PubMed ID: 18497677
    [Abstract] [Full Text] [Related]

  • 10. Risk factors and consequences of delayed graft function in deceased donor renal transplant patients receiving antithymocyte globulin induction.
    Patel SJ, Duhart BT, Krauss AG, Moore LW, Egidi MF, Amiri HS, Gaber LW, Gaber AO.
    Transplantation; 2008 Jul 27; 86(2):313-20. PubMed ID: 18645496
    [Abstract] [Full Text] [Related]

  • 11. Induction immunosuppression with rabbit antithymocyte globulin in pediatric liver transplantation.
    Shah A, Agarwal A, Mangus R, Lim J, Fridell J, Vianna R, Tector AJ.
    Liver Transpl; 2006 Aug 27; 12(8):1210-4. PubMed ID: 16868953
    [Abstract] [Full Text] [Related]

  • 12. Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy.
    Eason JD, Nair S, Cohen AJ, Blazek JL, Loss GE.
    Transplantation; 2003 Apr 27; 75(8):1396-9. PubMed ID: 12717237
    [Abstract] [Full Text] [Related]

  • 13. Induction therapy by anti-thymocyte globulin (rabbit) versus basiliximab in deceased donor renal transplants and the effect on delayed graft function and outcomes.
    Foster CE, Weng RR, Piper M, Laugenou K, Ichii H, Lakey J, Malinoski D.
    Transplant Proc; 2012 Jan 27; 44(1):164-6. PubMed ID: 22310605
    [Abstract] [Full Text] [Related]

  • 14. High dose rabbit antithymocyte globulin induction in living related liver transplantation.
    Masetti M, Montalti R, Arpinati M, Di Benedetto F, Miller CM, Zagnoli A, De Ruvo N, Guerrini GP, Romano A, Rondelli D, Chirumbolo G, Rompianesi G, Pinna AD, Gerunda GE.
    Hepatogastroenterology; 2007 Jan 27; 54(75):884-8. PubMed ID: 17591084
    [Abstract] [Full Text] [Related]

  • 15. Depleting antibody induction in simultaneous pancreas-kidney transplantation: a prospective single-center comparison of alemtuzumab versus rabbit anti-thymocyte globulin.
    Stratta RJ, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Doares W, Kaczmorski S, Farney AC.
    Expert Opin Biol Ther; 2014 Dec 27; 14(12):1723-30. PubMed ID: 25156622
    [Abstract] [Full Text] [Related]

  • 16. Low-dose thymoglobulin use in elderly renal transplant recipients is safe and effective induction therapy.
    Laftavi MR, Patel S, Soliman MR, Alnimri M, Kohli R, Said M, Pankewycz O.
    Transplant Proc; 2011 Mar 27; 43(2):466-8. PubMed ID: 21440735
    [Abstract] [Full Text] [Related]

  • 17. Steroid-free Liver Transplantation Using Rabbit Antithymocyte Globulin Induction in 500 Consecutive Patients.
    Yoo MC, Vanatta JM, Modanlou KA, Campos L, Nezakatgoo N, Nair S, Eason JD.
    Transplantation; 2015 Jun 27; 99(6):1231-5. PubMed ID: 25539464
    [Abstract] [Full Text] [Related]

  • 18. Induction therapy with either anti-CD25 monoclonal antibodies or rabbit antithymocyte globulins in liver transplantation for hepatitis C.
    Kamar N, Borde JS, Sandres-Saune K, Suc B, Barange K, Cointault O, Lavayssière L, Durand D, Izopet J, Rostaing L.
    Clin Transplant; 2005 Feb 27; 19(1):83-9. PubMed ID: 15659139
    [Abstract] [Full Text] [Related]

  • 19. Low-dose rabbit antithymocyte globulin versus basiliximab induction therapy in low-risk renal transplant recipients: 8-year follow-up.
    Laftavi MR, Alnimri M, Weber-Shrikant E, Kohli R, Said M, Patel S, Pankewycz O.
    Transplant Proc; 2011 Mar 27; 43(2):458-61. PubMed ID: 21440733
    [Abstract] [Full Text] [Related]

  • 20. Outcome of induction immunosuppression for liver transplantation comparing anti-thymocyte globulin, daclizumab, and corticosteroid.
    Uemura T, Schaefer E, Hollenbeak CS, Khan A, Kadry Z.
    Transpl Int; 2011 Jul 27; 24(7):640-50. PubMed ID: 21429047
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.